NCT00432614 - Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive Disorder | Biotech Hunter

Enrollment

510

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions

Major Depressive Disorder

Interventions

DRUG

SR58611A

oral administration

DRUG

escitalopram

oral administration

DRUG

placebo

oral administration

Trial Locations (13)

Sanofi-Aventis Administrative Office, Diegem

Sanofi-Aventis Administrative Office, Tatari

Sanofi-Aventis Administrative Office, Helsinki

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, Berlin

Sanofi-Aventis Administrative Office, Athens

Sanofi-Aventis Administrative Office, Mumbai

Sanofi-Aventis Administrative Office, Kuala Lumpur

Sanofi-Aventis Administrative Office, Casablanca

Sanofi-Aventis Administrative Office, Seoul

Sanofi-Aventis Administrative Office, Taipei

Sanofi-Aventis Administrative Office, Mégrine

Sanofi-Aventis Administrative Office, Istanbul